TipRanks
Fate Therapeutics (FATE)
NASDAQ:FATE
Want to see FATE full AI Analyst Report?

Compare Fate Therapeutics (FATE) vs. Competitors

1,294 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Fate Therapeutics
$2.57
$274.39M
-2.05
54.68%
4 Buy
3 Hold
0 Sell
Moderate Buy
Compugen
$2.84
$210.30M
5.73
22.16%
4 Buy
0 Hold
0 Sell
Strong Buy
Oncolytics Biotech
$0.86
$76.25M
-2.47
-55.93%
1 Buy
1 Hold
0 Sell
Moderate Buy
Cardiff Oncology
$1.02
$83.24M
-1.82
-51.34%
2 Buy
3 Hold
0 Sell
Moderate Buy
Nkarta
$2.63
$165.45M
-1.45
10.19%
5 Buy
0 Hold
0 Sell
Strong Buy
Shattuck Labs
$8.06
$588.13M
-11.09
130.82%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FATE
Fate Therapeutics
2.15
0.64
42.38%
CGEN
Compugen
2.15
0.34
18.78%
ONCY
Oncolytics Biotech
0.60
-0.69
-53.52%
TSE:ONC
―
―
―
―
CRDF
Cardiff Oncology
1.09
-1.29
-54.20%
NKTX
Nkarta
2.27
0.18
8.61%
STTK
Shattuck Labs
5.66
3.27
136.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts